Mundipharma expands biosimilar portfolio with exclusive partnership deal across seven European countries for trastuzumab biosimilar, Herzuma

Mar 20 2018

FOR EUROPEAN BUSINESS/TRADE MEDIA ONLY| PDF iconDownload PDF